Benefits of a comprehensive care model in patients with heart failure and preserved ejection fraction: The UMIPIC program

Rev Clin Esp (Barc). 2022 Jun-Jul;222(6):339-347. doi: 10.1016/j.rceng.2021.11.006. Epub 2022 Mar 9.

Abstract

Background: Patients with heart failure (HF) and preserved ejection fraction (HFpEF), in contrast to those with reduced ejection fraction, are older, have more comorbidities, and are not candidates for effective therapeutic measures. Therefore, they are at high risk for hospital admission and mortality. This study evaluated the benefit of a comprehensive continuous care program (UMIPIC program) in patients with HFpEF.

Methods: We prospectively analyzed data on 2401 patients with HFpEF attended to in internal medicine departments who form part of the RICA registry. They were divided into 2 groups: one was followed-up on in the UMIPIC program (UMIPIC group, n: 1011) and another received conventional care (RICA group, n: 1390). A total of 753 patients in each group were selected by propensity score matching and admissions and mortality were assessed during 12 months of follow-up after an episode of hospitalization due to HF.

Results: Compared to the RICA group, the UMIPIC group had a lower rate of HF admissions (19.2% versus 36.5%, respectively; hazard ratio [HR] = 0.56; 95% confidence interval [CI]: 0.45-0.68; p < 0.001) and mortality (12.6% versus 28%, respectively; HR = 0.40; 95% CI: 0.31-0.51; p < 0.001). There were no differences in hospitalizations for non-HF causes.

Conclusions: Implementation of the UMIPIC program, which is based on comprehensive continuous care, for patients with HFpEF and a high degree of comorbidity reduces both admissions and mortality in the first year of follow-up.

Keywords: Follow-up programs; Fracción de eyección preservada; Heart failure; Insuficiencia cardíaca; Preserved ejection fraction; Prognosis; Programas de seguimiento; Pronóstico.

MeSH terms

  • Heart Failure* / drug therapy
  • Heart Failure* / etiology
  • Hospitalization
  • Humans
  • Prognosis
  • Stroke Volume
  • Ventricular Function, Left